Postinjection delirium/sedation syndrome in patients with schizophrenia receiving olanzapine long-acting injection: Results from a large observational study

Postinjection delirium/sedation syndrome in patients with schizophrenia receiving olanzapine long-acting injection: Results from a large observational study

Background Postinjection delirium/sedation syndrome (PDSS) has been reported uncommonly during treatment with olanzapine long-acting injection (LAI), a sustained-release formulation of olanzapine. Aims...

Full description

Bibliographic Details
Main Authors:	Kristin J. Meyers, Himanshu P. Upadhyaya, John L. Landry, Rashna Chhabra-Khanna, Deborah M. Falk, Balasubramanya Seetharama Rao, Meghan E. Jones
Format:	Article
Language:	English
Published:	Cambridge University Press 2017-07-01
Series:	BJPsych Open
Online Access:	https://www.cambridge.org/core/product/identifier/S2056472400002234/type/journal_article

Similar Items

Postinjection delirium/sedation syndrome with olanzapine depot injection
by: Sadhvi Mythili Sarangula, et al.
Published: (2016-01-01)

Postinjection delirium/sedation syndrome in a transgender man undergoing hormone therapy
by: Joshua Gerving, PharmD, BCPS, BCPP, et al.
Published: (2023-08-01)

Is low body mass index a risk factor for postinjection delirium/sedation syndrome?
by: Zarine Maria Punnoose, et al.
Published: (2017-01-01)

Post-injection delirium/sedation syndrome in patients with schizophrenia treated with olanzapine long-acting injection, II: investigations of mechanism
by: Stickelmeyer Mary, et al.
Published: (2010-06-01)

Post-injection delirium/sedation syndrome in patients with schizophrenia treated with olanzapine long-acting injection, I: analysis of cases
by: Stefaniak Victoria J, et al.
Published: (2010-06-01)

The changes of immunologic parameters in patients with opioid narcomania with postinjected purulent-septic complications
by: G V Zhurbina, et al.
Published: (2009-12-01)

Olanzapine for the treatment of ICU delirium: a systematic review and meta-analysis
by: Si Bo Liu, et al.
Published: (2023-02-01)

Relationship Between Plasma Olanzapine and N-Desmethyl-Olanzapine Concentration and Metabolic Parameters in Patients With Schizophrenia
by: Huimei An, et al.
Published: (2022-06-01)

Application of Plasma Levels of Olanzapine and N-Desmethyl-Olanzapine to Monitor Clinical Efficacy in Patients with Schizophrenia.
by: Mong-Liang Lu, et al.
Published: (2016-01-01)

INHALATION SEDATION IN THOSE WITH SEPSIS-ASSOCIATED DELIRIUM
by: N. A. Rezepov, et al.
Published: (2018-01-01)

The role of temperature‐enhanced fault closure in promoting postinjection pressure diffusion and seismicity in enhanced geothermal systems
by: Yinlin Ji, et al.
Published: (2023-12-01)

Effectiveness and safety of olanzapine in the treatment of Asian outpatients with schizophrenia
by: Habil, H., et al.
Published: (2007)

Worth the Weight? Olanzapine Prescribing in Schizophrenia. A Review of Weight Gain and Other Cardiometabolic Side Effects of Olanzapine
by: Ita Fitzgerald, et al.
Published: (2021-09-01)

Subcutaneous Olanzapine at the End of Life in a Patient with Schizophrenia and Dysphagia
by: Jonathan Hindmarsh, et al.
Published: (2020-06-01)

Olanzapine-Samidorphan for Schizophrenia: A Systematic Review and Meta-Analysis
by: Dhyuti Gupta, et al.
Published: (2024-01-01)

Effects of olanzapine on anhedonia in schizophrenia: mediated by complement factor H
by: Yi Zhang, et al.
Published: (2023-07-01)

Effects of olanzapine on resting heart rate in Japanese patients with schizophrenia.
by: Misuzu Tajiri, et al.
Published: (2018-01-01)

Change in level of productivity in the treatment of schizophrenia with olanzapine or other antipsychotics
by: Osuntokun Olawale, et al.
Published: (2011-05-01)

Schizophrenia symptoms and functioning in patients receiving long-term treatment with olanzapine long-acting injection formulation: a pooled analysis
by: Peuskens Joseph, et al.
Published: (2012-08-01)

Clinical, electrophysiological, and prognostic study of postinjection sciatic nerve injury: An avoidable cause of loss of limb in the peripheral medical service
by: Wani Maqbool, et al.
Published: (2009-01-01)

Caudal block and emergence delirium in pediatric patients: Is it analgesia or sedation?
by: Aparna Sinha, et al.
Published: (2012-01-01)

Balancing sedation and ICU delirium management for better patient outcomes
by: Katarzyna Kotfis
Published: (2019-09-01)

Douleur, sédation et delirium : évaluation des patients sous sédation profonde aux soins intensifs
by: Eva Favre, et al.
Published: (2022-10-01)

Different Sedation Strategies in Older Patients Receiving Spinal Anesthesia for Hip Surgery on Postoperative Delirium: A Randomized Clinical Trial
by: Zhu S, et al.
Published: (2023-12-01)

Treatment with olanzapine, risperidone or typical antipsychotic drugs in Asian patients with schizophrenia
by: Lee, C., et al.
Published: (2006)

Effect of Co-Treatment of Olanzapine with SEP-363856 in Mice Models of Schizophrenia
by: Lingzhi Liang, et al.
Published: (2022-04-01)

Effect of Haloperidol and Olanzapine on Hippocampal Cells’ Proliferation in Animal Model of Schizophrenia
by: Jana Osacka, et al.
Published: (2022-07-01)

Topiramate Adjunctive Therapy for Olanzapine Induced Weight Gain in Patients with Schizophrenia
by: Sanjib Pandit, et al.
Published: (2019-08-01)

High-dose olanzapine in treatment-resistant schizophrenia: a systematic review
by: Louisa Gannon, et al.
Published: (2023-05-01)

Olanzapine versus typical neuroleptics for schizophrenia: evaluation of social and economic costs
by: Giorgio Mariani, et al.
Published: (2006-09-01)

A commentary on the efficacy of olanzapine for the treatment of schizophrenia: the past, present, and future
by: Citrome L, et al.
Published: (2019-09-01)

Genetic Association of Olanzapine Treatment Response in Han Chinese Schizophrenia Patients
by: Wei Zhou, et al.
Published: (2019-03-01)

Cost/effectiveness of aripiprazole vs. olanzapine in the long-term treatment of schizophrenia
by: Dutina Aleksandra, et al.
Published: (2019-01-01)

International Analgesia, Sedation, and Delirium Practices: a prospective cohort study
by: Gary D. Owen, et al.
Published: (2019-04-01)

Effect of olanzapine treatment on INR of a patient receiving warfarin therapy
by: Derya Arslan, et al.
Published: (2016-06-01)

Effect of olanzapine treatment on INR of a patient receiving warfarin therapy
by: Derya Arslan, et al.
Published: (2016-06-01)

An open-label clinical trial of oral transmucosal haloperidol and oral transmucosal olanzapine in the treatment of terminal delirium at home
by: Xiao-Juan Lyu, et al.
Published: (2022-04-01)

Effects of Aripiprazole on Olanzapine Population Pharmacokinetics and Initial Dosage Optimization in Schizophrenia Patients
by: Zhang C, et al.
Published: (2024-03-01)

Effect of Serum Leptin on Weight Gain Induced by Olanzapine in Female Patients with Schizophrenia.
by: Nobuto Tsuneyama, et al.
Published: (2016-01-01)

Profile of olanzapine long-acting injection for the maintenance treatment of adult patients with schizophrenia
by: Rosaria Di Lorenzo, et al.
Published: (2010-09-01)